Adhesive capsulitis: Pain & disability improved similarly with 20mg & 40mg corticosteroid .
Este estudio ha sido identificado como potencialmente de alto impacto.
La métrica de alto impacto de OE, impulsada por la IA, estima la influencia que probablemente tendrá un artículo integrando señales tanto de la revista en la que se publica como del contenido científico del propio artículo.
Desarrollado mediante el procesamiento del lenguaje natural más avanzado, el modelo de Alto Impacto de OE predice con mayor precisión el futuro rendimiento de las citas de un estudio que el factor de impacto de la revista por sí solo.
Esto permite reconocer antes las investigaciones clínicamente significativas y ayuda a los lectores a centrarse en los artículos con más probabilidades de configurar la práctica futura.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(10):33 Am J Sports Med. 2013 May;41(5):1133-9. doi: 10.1177/0363546513480475. Epub 2013 Mar 1863 patients were randomized to determine the effect of varying doses of corticosteroid injections in the treatment of adhesive capsulitis. Participants were allocated to groups of high-dose triamcinolone (40mg), low-dose triamcinolone (20mg), or placebo (control) (1% lidocaine). Results after 12 weeks indicated that pain and disability were more significantly improved with both dosages of corticosteroid compared to control, but there was no difference between 20mg and 40mg triamcinolone. Corticosteroid injections also had a beneficial effect on passive range of motion in flexion, abduction, and internal rotation
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sí = 1
Incierto = 0,5
No relevante = 0
No = 0
La evaluación de los criterios de información evalúa la transparencia con la que los autores informan de las características metodológicas y del ensayo dentro de la publicación. La evaluación se divide en cinco categorías que se presentan a continuación.
4/4
Randomization
3/4
Outcome Measurements
4/4
Inclusion / Exclusion
4/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
El Índice de Fragilidad es una herramienta que ayuda en la interpretación de hallazgos significativos, proporcionando una medida de fuerza para un resultado. El Índice de Fragilidad representa el número de eventos consecutivos que es necesario añadir a un resultado dicotómico para que el hallazgo deje de ser significativo. Un número pequeño representa un hallazgo más débil y un número grande un hallazgo más fuerte.
¿Por qué se necesitaba ahora este estudio?
Although intra-articular injections of corticosteroid have been and remain a mainstay in the treatment of adhesive capsulitis, there is little evidence available to guide clinician decision-making with respect to dosage. It has been suggested that the efficacy of steroid injections conforms to a dose-dependent relationship, with increasing dose leading to a more favourable outcome. Yet, simultaneously, the severity of cartilage damage linked to corticosteroid injection is also thought to be manifested through the same dose dependency. Therefore, it has become crucial to determine the optimal steroid dosage to use in the treatment of adhesive capsulitis.
¿Cuál era la pregunta principal de la investigación?
What was the comparative efficacy of 20mg triamcinolone acetonide, 40mg triamcinonlone acetonide, and placebo in adhesive capsulitis treatment?
- SPADI scores were reduced from 37.9 (SD 14.2) at baseline to 14.1 (SD 12.4) at 12 weeks in the high-dose group, 37.6 (SD 13.7) to 18.3 (SD 14.0) in the low-dose group, and 44.2 (SD 12.2) to 37.1 (SD 10.4) in the placebo group. Improvements in both the high-dose and low-dose steroid groups were significant compared to placebo (P<0.001 and P=0.001, respectively), although the difference between steroid groups was not significant (P=0.826).
- Marked reductions in VAS pain were observed for the steroid groups; the high-dose group from 5.2 (SD 1.7) at baseline to 2.4 (SD 1.7) at 12 weeks, and the low-dose group from 4.9 (SD 1.3) to 2.4 (SD 1.3). The difference between these two group was not significant (P=0.999). Compared to placebo (reduction from 5.5 to 4.6), both steroid groups were observed to have a significantly greater reduction (High-dose: P<0.001; Low-dose: P=0.001).
- Flexion, abduction, and internal rotation were significantly better in the high- and low-dose groups compared to placebo group (all P<0.005). The difference between the steroid groups was not significant for these measurements, however (P=0.485, 0.092, and 0.495, respectively).
- The group-by-time interactions for extension and external rotation were not significant (P=0.331 and 0.094, respectively), however the group-by-time interactions for SPADI (P=0.007), VAS (P=0.004), flexion (P=0.024), abduction (P<0.001) and internal rotation (P=0.027) were all significant.
- Facial flushing was observed in 3 high-dose participants and 1 low-dose participant. Dizziness due to a vasovagal reaction occurred in 1 patient of the placebo group and 1 in the low-dose group. These were the only complications reported.
¿Qué es lo que más debo recordar?
Injection of either 20mg or 40mg triamcinolone acetonide led to significantly reduced pain and disability compared to a control injection in the treatment of adhesive capsulitis. Furthermore, improved range of motion was observed with the corticosteroid injections. There were no differences in outcomes based on dose of triamcinolone acetonide received, and neither dose was associated with any serious adverse event.
¿Cómo afectará esto al cuidado de mis pacientes?
At 12 weeks post injection there appears to be no difference between a lower (20mg) and a higher dose (40mg) of triamcinolone. Given the lack of difference, a lower dose may be considered to avoid any potential complications that may exist with higher doses (even though the study found none). However, further investigation with a larger cohort of patients is required to confirm the efficacies of both high- and low-dose corticosteroid injections. Long-term effect of single injections should also be determined in future studies.
DESCARGO DE RESPONSABILIDAD
El contenido de esta página tiene únicamente fines informativos y no pretende sustituir el consejo, diagnóstico o tratamiento médico profesional. Si necesita tratamiento médico, busque siempre el consejo de su médico o acuda al servicio de urgencias más cercano. Las opiniones, creencias y puntos de vista expresados por las personas sobre el contenido que se encuentra en esta página no reflejan las opiniones, creencias y puntos de vista de OrthoEvidence.
0 de 4 artículos mensuales GRATIS desbloqueados
